Domperidone
搜索文档
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
Accessnewswire· 2025-10-29 02:10
FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Momentum has a way of separating the contenders from the crowd. Sunshine Biopharma (NASDAQ: SBFM ) is quickly establishing which side of that line it's on. ...
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
Accessnewswire· 2025-10-28 19:45
公司动态 - 子公司Nora Pharma Inc获得加拿大卫生部对处方药多潘立酮的商业化批准 [1] - 多潘立酮用于缓解恶心呕吐及增强胃肠动力 [1] - 该药物特别适用于化疗引起的恶心呕吐 尤其当患者无法耐受可能引起锥体外系副作用的其他止吐药时 [1] 产品信息 - 多潘立酮为处方药 [1] - 药物适应症包括缓解恶心呕吐和增强胃肠道蠕动 [1] - 目标患者群体为化疗引起恶心呕吐且对其他止吐药不耐受者 [1] 监管进展 - 批准机构为加拿大卫生部 其为加拿大相当于美国FDA的监管机构 [1] - 此次批准针对药物在加拿大的商业化 [1]